BALAXI PHARMACEUTICALS LIMITED — Important, 30-05-2025: General Updates

Balaxi Pharmaceuticals has announced a board meeting on August 25, 2025. Consolidated revenue stood at Rs. 258.44 Cr with a net profit of Rs. 10.93 Cr for the year. The standalone business posted Rs. 60.99 Cr revenue and Rs. 3.60 Cr net profit. The new formulation plant in Jadcherla is nearing operational start as machinery installation is complete and validation is in progress, with the manufacturing license expected soon. Audit functions have been renewed with key appointments for internal and secretarial audits.